These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 1820907

  • 1. Pharmacokinetics of butyric acid derivative with xylitol.
    Desmet G, Brazier M, Cerutti J, Chany C, Arnould-Guerin ML.
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():348-51. PubMed ID: 1820907
    [Abstract] [Full Text] [Related]

  • 2. [Protective activity of monoacetone glucose 3-butyrate, prodrug of n-butyric acid, against the fatal effect of encephalomyocarditis virus in mice].
    Pouillart P, Cerutti I, Ronco G, Villa P, Chany C.
    C R Acad Sci III; 1992; 314(2):49-54. PubMed ID: 1313734
    [Abstract] [Full Text] [Related]

  • 3. Effects of arginine butyrate and tributyrylxylitol on cultured human sarcoma cells.
    Vincent-Fiquet O, Rogez JC, Boitte F, Brazier M, Desmet G.
    Anticancer Res; 1994; 14(5A):1823-8. PubMed ID: 7531414
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetic study of butyric acid administered in vivo as sodium and arginine butyrate salts.
    Daniel P, Brazier M, Cerutti I, Pieri F, Tardivel I, Desmet G, Baillet J, Chany C.
    Clin Chim Acta; 1989 May 31; 181(3):255-63. PubMed ID: 2667816
    [Abstract] [Full Text] [Related]

  • 5. Low level toxicity and antitumor activity of butyric mono- and polyester monosaccharide derivates in mice.
    Pouillart P, Ronco G, Cerutti I, Chany C, Villa P.
    J Biol Regul Homeost Agents; 1990 May 31; 4(4):135-41. PubMed ID: 2096598
    [Abstract] [Full Text] [Related]

  • 6. A retinoid/butyric acid prodrug overcomes retinoic acid resistance in leukemias by induction of apoptosis.
    Mann KK, Rephaeli A, Colosimo AL, Diaz Z, Nudelman A, Levovich I, Jing Y, Waxman S, Miller WH.
    Mol Cancer Res; 2003 Oct 31; 1(12):903-12. PubMed ID: 14573791
    [Abstract] [Full Text] [Related]

  • 7. Esterase inhibitors diminish the modulation of gene expression by butyric acid derivative, pivaloyloxymethyl butyrate (AN-9).
    Rabizadeh E, Shaklai M, Eisenbach L, Nudelman A, Rephaeli A.
    Isr J Med Sci; 1996 Dec 31; 32(12):1186-91. PubMed ID: 9007151
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Drug delivery systems: water soluble taxol 2'-poly(ethylene glycol) ester prodrugs-design and in vivo effectiveness.
    Greenwald RB, Gilbert CW, Pendri A, Conover CD, Xia J, Martinez A.
    J Med Chem; 1996 Jan 19; 39(2):424-31. PubMed ID: 8558510
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Butyrates, as a single drug, induce histone acetylation and granulocytic maturation: possible selectivity on core binding factor-acute myeloid leukemia blasts.
    Gozzini A, Rovida E, Dello Sbarba P, Galimberti S, Santini V.
    Cancer Res; 2003 Dec 15; 63(24):8955-61. PubMed ID: 14695213
    [Abstract] [Full Text] [Related]

  • 13. Novel mutual prodrug of retinoic and butyric acids with enhanced anticancer activity.
    Nudelman A, Rephaeli A.
    J Med Chem; 2000 Jul 27; 43(15):2962-6. PubMed ID: 10956204
    [Abstract] [Full Text] [Related]

  • 14. Induction of apoptosis by monosaccharide butyrate stable derivatives in chronic lymphocytic leukemia cells.
    Santini V, Gozzini A, Scappini B, Caporale R, Zoccolante A, Rigacci L, Gelardi E, Grossi A, Alterini R, Ferrini PR.
    Haematologica; 1999 Oct 27; 84(10):897-904. PubMed ID: 10509037
    [Abstract] [Full Text] [Related]

  • 15. Derivatives of butyric acid as potential anti-neoplastic agents.
    Rephaeli A, Rabizadeh E, Aviram A, Shaklai M, Ruse M, Nudelman A.
    Int J Cancer; 1991 Aug 19; 49(1):66-72. PubMed ID: 1874573
    [Abstract] [Full Text] [Related]

  • 16. Cholesteryl butyrate in solid lipid nanospheres as an alternative approach for butyric acid delivery.
    Pellizzaro C, Coradini D, Morel S, Ugazio E, Gasco MR, Daidone MG.
    Anticancer Res; 1999 Aug 19; 19(5B):3921-5. PubMed ID: 10628332
    [Abstract] [Full Text] [Related]

  • 17. Regioselective synthesis and biological profiling of butyric and phenylalkylcarboxylic esters derivated from D-mannose and xylitol: influence of alkyl chain length on acute toxicity.
    Pouillart P, Douillet O, Scappini B, Gozzini A, Santini V, Grossi A, Pagliai G, Strippoli P, Rigacci L, Ronco G, Villa P.
    Eur J Pharm Sci; 1999 Jan 19; 7(2):93-106. PubMed ID: 9845786
    [Abstract] [Full Text] [Related]

  • 18. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
    Engel D, Nudelman A, Tarasenko N, Levovich I, Makarovsky I, Sochotnikov S, Tarasenko I, Rephaeli A.
    J Med Chem; 2008 Jan 24; 51(2):314-23. PubMed ID: 18163551
    [Abstract] [Full Text] [Related]

  • 19. A phase I study of pivaloyloxymethyl butyrate, a prodrug of the differentiating agent butyric acid, in patients with advanced solid malignancies.
    Patnaik A, Rowinsky EK, Villalona MA, Hammond LA, Britten CD, Siu LL, Goetz A, Felton SA, Burton S, Valone FH, Eckhardt SG.
    Clin Cancer Res; 2002 Jul 24; 8(7):2142-8. PubMed ID: 12114414
    [Abstract] [Full Text] [Related]

  • 20. In vitro and in vivo evaluations of the metabolism, pharmacokinetics, and bioavailability of ester prodrugs of L-767,679, a potent fibrinogen receptor antagonist: an approach for the selection of a prodrug candidate.
    Prueksaritanont T, Gorham LM, Breslin MJ, Hutchinson JH, Hartman GD, Vyas KP, Baillie TA.
    Drug Metab Dispos; 1997 Aug 24; 25(8):978-84. PubMed ID: 9280406
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.